HEMANGIOMA

Clinical trials for HEMANGIOMA explained in plain language.

Never miss a new study

Get alerted when new HEMANGIOMA trials appear

Sign up with your email to follow new studies for HEMANGIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1

New hope for rare blood vessel disorders: everolimus trial launches

Disease control Not yet recruiting

This study tests the drug everolimus in 67 people with certain blood vessel growths or malformations that did not improve with other treatments. The goal is to see if everolimus can shrink these growths or improve symptoms. Participants take the drug by mouth, and doctors monitor…

Matched conditions: HEMANGIOMA

Phase: PHASE2 • Sponsor: Yonsei University • Aim: Disease control

Last updated May 22, 2026 13:51 UTC

HEMANGIOMA

Get alerted when new HEMANGIOMA trials appear

New hope for rare blood vessel disorders: everolimus trial launches